{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:03:04Z","timestamp":1790521384555,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T00:00:00Z","timestamp":1182470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T00:00:00Z","timestamp":1182470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11908-007-0047-7","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T05:23:12Z","timestamp":1182403392000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Changing epidemiology of bacterial meningitis"],"prefix":"10.1007","volume":"9","author":[{"given":"MarkAlain","family":"Dery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Hasbun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,22]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/infdis\/162.6.1316","volume":"162","author":"J.D. Wenger","year":"1990","unstructured":"Wenger JD, Hightower AW, Facklam RR, et al.: Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990, 162:1316\u20131323.","journal-title":"J Infect Dis"},{"key":"47_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJM199710023371404","volume":"337","author":"A. Schuchat","year":"1997","unstructured":"Schuchat A, Robinson K, Wenger JD, et al.: Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997, 337:970\u2013976.","journal-title":"N Engl J Med"},{"key":"47_CR3","unstructured":"Thigpen MC, Rosenstein N, Whitney C, et al.: Bacterial meningitis in the United States: 1998\u20132003 [abstract #65]. Presented at the 43rd Annual Infectious Diseases Society Meeting. San Francisco; October 9, 2005."},{"issue":"RR-11","key":"47_CR4","first-page":"1","volume":"51","author":"S. Schrag","year":"2002","unstructured":"Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A: Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Morb Mortal Wkly Rep 2002, 51(RR-11):1\u201322.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"47_CR5","first-page":"232","volume":"98","author":"M. Kainer","year":"2005","unstructured":"Kainer M, McCauley T, Craig AS: Prevention of early-onset group B streptococcal disease in newborn. Tenn Med 2005, 98:232\u2013233.","journal-title":"Tenn Med"},{"key":"47_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1086\/381197","volume":"38","author":"J. Ruhe","year":"2004","unstructured":"Ruhe J, Myers L, Mushatt D, Hasbun R: High-level penicillin-nonsusceptible Streptococcus pneumoniae bacteremia: identification of a low-risk subgroup. Clin Infect Dis 2004, 38:508\u2013514.","journal-title":"Clin Infect Dis"},{"key":"47_CR7","first-page":"234","volume":"51","author":"Centers for Disease ControlPrevention","year":"2002","unstructured":"Centers for Disease Control and Prevention (CDC): Progress toward elimination of Haemophilus influenzae Type b invasive disease among infants and children\u2014United States, 1998\u20132000. MMWR Morb Mortal Wkly Rep 2002, 51:234\u2013237.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"47_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1128\/CMR.13.2.302-317.2000","volume":"13","author":"H. Peltola","year":"2000","unstructured":"Peltola H: Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: Global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000, 13:302\u2013317.","journal-title":"Clin Microbiol Rev"},{"key":"47_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00006454-199102000-00004","volume":"10","author":"S.B. Black","year":"1991","unstructured":"Black SB, Shinefield HR, Fireman B, et al.: Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J 1991, 10:97\u2013104.","journal-title":"Pediatr Infect Dis J"},{"key":"47_CR10","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJM199106203242503","volume":"324","author":"M. Santosham","year":"1991","unstructured":"Santosham M, Wolff M, Reid R, et al.: The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitides outer-membrane protein complex. N Eng J Med 1991, 324:1767\u20131772.","journal-title":"N Eng J Med"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/164.5.982","volume":"164","author":"A.K. Takala","year":"1991","unstructured":"Takala AK, Eskola J, Leinonen M, et al.: Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991, 164:982\u2013986.","journal-title":"J Infect Dis"},{"key":"47_CR12","first-page":"170","volume":"35","author":"Centers for Disease ControlPrevention","year":"1986","unstructured":"Centers for Disease Control and Prevention (CDC): Prevention of Haemophilus influenzae type b disease. MMWR Morb Mortal Wkly Rep 1986, 35:170\u2013174, 179\u2013180.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"47_CR13","unstructured":"Recommendations for the use of Haemophilus influenzae b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993, 42(RR-13):1\u201315."},{"key":"47_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1099\/jmm.0.46579-0","volume":"55","author":"S.C. Clark","year":"2006","unstructured":"Clark SC: Control of pneumococcal disease in the United Kingdom\u2014the start of a new era. J Med Microbiol 2006, 55:975\u2013980.","journal-title":"J Med Microbiol"},{"key":"47_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/0140-6736(92)92117-X","volume":"340","author":"H. Peltola","year":"1992","unstructured":"Peltola H, Kilpi T: Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992, 340:592\u2013594.","journal-title":"Lancet"},{"key":"47_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/00365540110080403","volume":"34","author":"M. Kyaw","year":"2002","unstructured":"Kyaw M, Christie P, Jones I, Campbell H: The changing epidemiology of bacterial meningitis and invasive non-meningitic bacterial disease in Scotland during the period of 1983\u201399. Scand J Infect Dis 2002, 34:289\u2013298.","journal-title":"Scand J Infect Dis"},{"key":"47_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0264-410X(99)00269-8","volume":"18","author":"J.D. Wenger","year":"1999","unstructured":"Wenger JD, DiFabio J, Landaverde JM, et al.: Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four \u2018newly adopting\u2019 countries. Vaccine 1999, 18:736\u2013742.","journal-title":"Vaccine"},{"key":"47_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2334-5-103","volume":"5","author":"F.O. Dickinson","year":"2005","unstructured":"Dickinson FO, Perez A: Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system. BMC Infect Dis 2005, 5:103.","journal-title":"BMC Infect Dis"},{"key":"47_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1001\/jama.296.6.671","volume":"296","author":"K.D. Cowgill","year":"2006","unstructured":"Cowgill KD, Ndiritu M, Nyiro J, et al.: Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006, 296:671\u2013678.","journal-title":"JAMA"},{"key":"47_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/jama.269.2.227","volume":"269","author":"L.E. Broadhurst","year":"1993","unstructured":"Broadhurst LE, Erickson RL, Kelley PW: Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991. JAMA 1993, 269:227\u2013231.","journal-title":"JAMA"},{"key":"47_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1086\/314535","volume":"179","author":"H. Peltola","year":"1999","unstructured":"Peltola H, Aavitsland P, Hansen KG, et al.: Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. J Infect Dis 1999, 179:223\u2013229.","journal-title":"J Infect Dis"},{"key":"47_CR22","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1016\/j.vaccine.2006.05.076","volume":"24","author":"P. Daza","year":"2006","unstructured":"Daza P, Banda R, Misoya K, et al.: The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 2006, 24:6232\u20136239.","journal-title":"Vaccine"},{"key":"47_CR23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/00006454-199708000-00010","volume":"16","author":"H. Peltola","year":"1997","unstructured":"Peltola H: Haemophilus influenzae type b disease and vaccination in Latin America and the Caribbean. Pediatr Infect Dis J 1997, 16:780\u2013787.","journal-title":"Pediatr Infect Dis J"},{"key":"47_CR24","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","volume":"285","author":"K.A. Robinson","year":"2001","unstructured":"Robinson KA, Baughman W, Rothrock G, et al.: Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998: opportunities for prevention in the conjugate vaccine era. JAMA 2001, 285:1729\u20131735.","journal-title":"JAMA"},{"key":"47_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/aje\/kwh082","volume":"159","author":"K.L. O\u2019Brien","year":"2004","unstructured":"O\u2019Brien KL, Santosham M: Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. Am J Epidemiol 2004, 159:634\u2013643.","journal-title":"Am J Epidemiol"},{"key":"47_CR26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/brain\/awg113","volume":"126","author":"S. Kastenbauer","year":"2003","unstructured":"Kastenbauer S, Pfister HW: Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003, 126:1015\u20131025.","journal-title":"Brain"},{"key":"47_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/bmb\/ldh041","volume":"72","author":"S. Segal","year":"2004","unstructured":"Segal S, Pollard AJ: Vaccines against bacterial meningitis. Brit Med Bull 2004, 72:65\u201381.","journal-title":"Brit Med Bull"},{"issue":"RR09","key":"47_CR28","first-page":"1","volume":"49","author":"Centers for Disease ControlPrevention","year":"2000","unstructured":"Centers for Disease Control and Prevention (CDC): Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000, 49(RR09):1\u201338.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"47_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00006454-200004000-00036","volume":"19","author":"H.R. Shinefield","year":"2000","unstructured":"Shinefield HR, Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J 2000, 19:394\u2013397.","journal-title":"Pediatr Infect Dis J"},{"key":"47_CR30","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa022823","volume":"348","author":"C.G. Whitney","year":"2003","unstructured":"Whitney CG, Farley MM, Hadler J, et al.: Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Eng J Med 2003, 348:1737\u20131746.","journal-title":"N Eng J Med"},{"key":"47_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1542\/peds.113.3.443","volume":"113","author":"S.L. Kaplan","year":"2004","unstructured":"Kaplan SL, Mason EO, Wald ER, et al.: Decrease of invasive pneumococcal infections in children among 8 children\u2019s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004, 113:443\u2013449.","journal-title":"Pediatrics"},{"key":"47_CR32","first-page":"893","volume":"54","author":"Centers for Disease ControlPrevention","year":"2005","unstructured":"Centers for Disease Control and Prevention (CDC): Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003. MMWR Morb Mortal Wkly Rep 2005, 54:893\u2013897.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"47_CR33","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","volume":"295","author":"K.A. Poehling","year":"2006","unstructured":"Poehling KA, Talbot TR, Griffin MR, et al.: Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006, 295:1668\u20131674.","journal-title":"JAMA"},{"key":"47_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0009922806289322","volume":"46","author":"M. Abuelreish","year":"2007","unstructured":"Abuelreish M, Subedar A, Chiu T, et al.: Increase in invasive pneumococcal disease in children associated with shortage of heptavalent pneumococcal conjugate vaccine. Clin Pediatr (Phila) 2007, 46:45\u201352.","journal-title":"Clin Pediatr (Phila)"},{"key":"47_CR35","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1097\/01.CCM.0000239434.26669.65","volume":"34","author":"M. Auburtin","year":"2006","unstructured":"Auburtin M, Wolff M, Charpentier J, et al.: Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 2006, 34:2758\u20132765.","journal-title":"Crit Care Med"},{"key":"47_CR36","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMoa051642","volume":"354","author":"M.H. Kyaw","year":"2006","unstructured":"Kyaw MH, Lynfield R, Schaffner W, et al.: Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumonia. N Engl J Med 2006, 354:1455\u20131463.","journal-title":"N Engl J Med"},{"key":"47_CR37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","volume":"51","author":"P. Balmer","year":"2002","unstructured":"Balmer P, Borrow R, Miller E: Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 2002, 51:717\u2013722.","journal-title":"J Med Microbiol"},{"key":"47_CR38","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1086\/344273","volume":"35","author":"J.F. Brundage","year":"2002","unstructured":"Brundage, JF, Ryan MA, Feighner BH, Erdtmann FJ: Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964\u20131998. Clin Infect Dis 2002, 35:1376\u20131381.","journal-title":"Clin Infect Dis"},{"key":"47_CR39","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1056\/NEJMcp063561","volume":"355","author":"P. Gardner","year":"2006","unstructured":"Gardner P: Prevention of meningococcal disease. N Engl J Med 2006, 355:1466\u20131473.","journal-title":"N Engl J Med"},{"key":"47_CR40","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1086\/377739","volume":"37","author":"A. Antignac","year":"2003","unstructured":"Antignac A, Ducos-Galand M, Guiyole A, et al.: Neisseria meningitides strains isolated from invasive infections in France (1999\u20132002): phenotypes and antibiotic susceptibility patterns. Clin Infect Dis 2003, 37:912\u2013920.","journal-title":"Clin Infect Dis"},{"key":"47_CR41","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","volume":"344","author":"N.E. Rosenstein","year":"2001","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, et al.: Meningococcal disease. N Engl J Med 2001, 344:1378\u20131388.","journal-title":"N Engl J Med"},{"key":"47_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","volume":"326","author":"M.E. Ramsay","year":"2003","unstructured":"Ramsay ME, Andrews NJ, Trotter CL, et al.: Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 2003, 326:365\u2013366.","journal-title":"BMJ"},{"issue":"Suppl1","key":"47_CR43","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","volume":"20","author":"E. Miller","year":"2001","unstructured":"Miller E, Salisbury D, Ramsay M: Planning, registration, and implementation of an immunization campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 2001, 20(Suppl 1):S58\u2013S67.","journal-title":"Vaccine"},{"key":"47_CR44","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1365-3156.2006.01639.x","volume":"11","author":"B. Greenwood","year":"2006","unstructured":"Greenwood B: Editorial: 100 years of epidemic meningitis in West Africa-has anything changed?\n                           Trop Med Int Health 2006, 11:773\u2013780.","journal-title":"Trop Med Int Health"},{"key":"47_CR45","first-page":"645","volume":"55","author":"M.H. Wahdan","year":"1977","unstructured":"Wahdan MH, Sallam SA, Hassan MN, et al.: A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Bull World Health Organ 1977, 55:645\u2013651.","journal-title":"Bull World Health Organ"},{"key":"47_CR46","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/infdis\/171.3.632","volume":"171","author":"P.A. Twumasi","year":"1995","unstructured":"Twumasi PA, Kumah S, Leach A, et al.: A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis 1995, 171:632\u2013638.","journal-title":"J Infect Dis"},{"key":"47_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199301000-00001","volume":"72","author":"D.W. Dunne","year":"1993","unstructured":"Dunne DW, Quagliarello V: Group B streptococcal meningitis in adults. Medicine (Baltimore) 1993, 72:1\u201310.","journal-title":"Medicine (Baltimore)"},{"key":"47_CR48","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa012657","volume":"347","author":"B.J. Stoll","year":"2002","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, et al.: Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347:240\u2013247.","journal-title":"N Engl J Med"},{"key":"47_CR49","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrmicro1552","volume":"4","author":"A. Johri","year":"2006","unstructured":"Johri A, Paoletti LC, Glaser P, et al.: Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006, 4:932\u2013942.","journal-title":"Nat Rev Microbiol"},{"key":"47_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00005792-199809000-00002","volume":"77","author":"E. Mylonakis","year":"1998","unstructured":"Mylonakis E, Hohmann EL, Calderwood SB: Central nervous system infection with Listeria monocytogenes. 33 years\u2019 experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore) 1998, 77:313\u2013336","journal-title":"Medicine (Baltimore)"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0047-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-007-0047-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0047-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0047-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T12:43:10Z","timestamp":1744029790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-007-0047-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,22]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s11908-007-0047-7","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,22]]},"assertion":[{"value":"22 June 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}